RNA - Avidity Biosciences  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RNA is currently covered by 10 analysts with an average price target of $92.93. This is a potential upside of $20.8 (28.84%) from yesterday's end of day stock price of $72.13.

Avidity Biosciences 's activity chart (see below) currently has 76 price targets and 82 ratings on display. The stock rating distribution of RNA is 96.15% BUY and 3.85% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.52% with an average time for these price targets to be met of 374.77 days.

Highest price target for RNA is $96, Lowest price target is $59, average price target is $71.5.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 11-Nov-2025. First documented stock forecast 07-Jul-2020.

Currently out of the existing stock ratings of RNA, 25 are a BUY (96.15%), 1 are a HOLD (3.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$72

$0.3 (0.42%)

$72

1 months 16 days ago
(11-Nov-2025)

12/16 (75%)

$1.3 (1.84%)

283

Buy

$74

$2.3 (3.21%)

$78

1 months 28 days ago
(29-Oct-2025)

0/2 (0%)

$4.35 (6.25%)

Buy

$72

$0.3 (0.42%)

$61

1 months 29 days ago
(28-Oct-2025)

3/4 (75%)

$2.07 (2.96%)

285

Buy

$72

$0.3 (0.42%)

$18

2 months ago
(27-Oct-2025)

3/4 (75%)

$2 (2.86%)

989

Buy

$65

$-6.7 (-9.34%)

$65

2 months ago
(27-Oct-2025)

17/18 (94.44%)

$-5 (-7.14%)

255

Show more analysts

Please expand the browser size to see the chart

What is RNA (Avidity Biosciences ) average time for price targets to be met?

On average it took 374.77 days on average for the stock forecasts to be realized with a an average price target met ratio 67.52

Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?

YANAN ZHU

Which analyst has the most public recommendations on RNA (Avidity Biosciences )?

Yanan Zhu works at WELLS FARGO and has 4 price targets and 2 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences )?

Eric Schmidt with highest potential upside - $24.3

Which analyst is the currently most reserved on RNA (Avidity Biosciences )?

Judah Frommer with lowest potential downside - -$41.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?